MedTrace Logo

Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF)

NCT02645656 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-01-05

No results posted yet for this study

Summary

Curcumin (diferuloylmethane) is the chief component of the spice turmeric and is derived from the rhizome of the East Indian plant Curcuma longa. Curcuma longais a member of the Zingiberacae (ginger) family of botanicals and is a perennial plant that is native to Southeast Asia. Turmeric contains a class of compounds known as the curcuminoids, comprised of curcumin, demethoxy curcumin and bisdemethoxycurcumin.

Conditions

  • Oral Submucous Fibrosis

Interventions

DRUG

Curcumin Arm

Curcumin gel will be applied in sites with Oral Submucous Fibrosis at designated time intervals

Sponsors & Collaborators

  • SVS Institute of Dental Sciences

    lead OTHER

Principal Investigators

  • Ramaraju Devaraju, MDS · Academic Commitee

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • India

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02645656 on ClinicalTrials.gov